| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.1B | $0.8B | $3.7B | $3.7B | $2.9B | $0.7B | $0.7B | $0.8B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $0.2B | $0.1B | $0.4B | $0.4B | $0.4B | $0.1B | $0.1B | $0.1B |
| Net Income | $0.1B | $-1.4B | $0.2B | $0.2B | $0.2B | $0.1B | $0.1B | $0.1B |
| EPS (Basic) | $0.71 | $-0.40 | $1.82 | $2.20 | $2.25 | $0.46 | $0.61 | $0.46 |
| EPS (Diluted) | $0.71 | $-0.40 | $1.81 | $2.20 | $2.25 | $0.46 | $0.61 | $0.45 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $8.9B | $8.9B | $17.2B | $16.3B | $15.8B | $15.0B | $13.7B | $13.1B |
| Current Assets | $1.9B | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.5B | $0.8B | $0.7B | $0.2B | $0.3B | $0.3B | $0.2B | — |
| Total Liabilities | $7.3B | $7.4B | $14.9B | $14.0B | $13.4B | $12.6B | $11.4B | $10.9B |
| Current Liabilities | $1.4B | — | — | — | — | — | — | — |
| Stockholders' Equity | $1.6B | $1.5B | $2.3B | $2.2B | $2.4B | $2.3B | $2.3B | $2.2B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.4B | $0.5B | $0.6B | $0.5B | $0.4B | $0.4B | $0.5B | $0.5B |
| Investing Cash Flow | $-0.3B | $0.3B | $-0.3B | $-1.1B | $-1.2B | $-1.4B | $-0.5B | $-0.8B |
| Capital Expenditures | $0.3B | $0.3B | $0.4B | $0.3B | $0.3B | $0.4B | $0.5B | $0.5B |
| Financing Cash Flow | $-0.3B | $0.2B | $0.2B | $0.6B | $0.8B | $1.1B | $0.1B | $0.2B |